Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Neefjes

Showing results (171-180 of 211) with videos related to

Pageof 22
Sort By:
Cancers|May 16, 2023
Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In VitroMaaike Y Kapteijn, Shanna Zwaan, Esther Ter Linden, et al.
Iscience|June 28, 2024
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognitionTom A W Schoufour, Anneloes van der Plas-van Duijn, Ian Derksen, et al.
Genes & Development|May 17, 2006
DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2ASteven Bergink, Florian A Salomons, Deborah Hoogstraten, et al.
The EMBO Journal|April 30, 2011
LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activationFrederik J Verweij, Monique A J van Eijndhoven, Erik S Hopmans, et al.
Cell Reports|December 9, 2020
Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT MotifsBirol Cabukusta, Ilana Berlin, Daphne M van Elsland, et al.
Cell Reports|July 13, 2023
Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT MotifsBirol Cabukusta, Ilana Berlin, Daphne M van Elsland, et al.
Cell|April 5, 2011
A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentationPetra Paul, Tineke van den Hoorn, Marlieke L M Jongsma, et al.
Molecular Cancer|June 3, 2024
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patientsXiaohang Qiao, Sabina Y van der Zanden, Xiaoyang Li, et al.
Nature Chemical Biology|May 17, 2016
A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymesMonique P C Mulder, Katharina Witting, Ilana Berlin, et al.
American Journal of Hematology|October 30, 2018
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expressionFloris C Loeff, Kevin Rijs, Esther H M van Egmond, et al.
Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
Cancers|May 16, 2023
Temozolomide and Lomustine Induce Tissue Factor Expression and Procoagulant Activity in Glioblastoma Cells In VitroMaaike Y Kapteijn, Shanna Zwaan, Esther Ter Linden, et al.
Iscience|June 28, 2024
CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognitionTom A W Schoufour, Anneloes van der Plas-van Duijn, Ian Derksen, et al.
Genes & Development|May 17, 2006
DNA damage triggers nucleotide excision repair-dependent monoubiquitylation of histone H2ASteven Bergink, Florian A Salomons, Deborah Hoogstraten, et al.
The EMBO Journal|April 30, 2011
LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activationFrederik J Verweij, Monique A J van Eijndhoven, Erik S Hopmans, et al.
Cell Reports|December 9, 2020
Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT MotifsBirol Cabukusta, Ilana Berlin, Daphne M van Elsland, et al.
Cell Reports|July 13, 2023
Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT MotifsBirol Cabukusta, Ilana Berlin, Daphne M van Elsland, et al.
Cell|April 5, 2011
A Genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentationPetra Paul, Tineke van den Hoorn, Marlieke L M Jongsma, et al.
Molecular Cancer|June 3, 2024
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patientsXiaohang Qiao, Sabina Y van der Zanden, Xiaoyang Li, et al.
Nature Chemical Biology|May 17, 2016
A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymesMonique P C Mulder, Katharina Witting, Ilana Berlin, et al.
American Journal of Hematology|October 30, 2018
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expressionFloris C Loeff, Kevin Rijs, Esther H M van Egmond, et al.
Pageof 22